Sökning: id:"swepub:oai:lup.lub.lu.se:85a3970c-8fe0-4d31-8b5d-2ee6b2130ceb" >
Refining the Defini...
-
Frohnert, Brigitte I.University of Colorado
(författare)
Refining the Definition of Stage 1 Type 1 Diabetes : An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
2023-03-02
-
American Diabetes Association,2023
-
9 s.
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:85a3970c-8fe0-4d31-8b5d-2ee6b2130ceb
-
https://lup.lub.lu.se/record/85a3970c-8fe0-4d31-8b5d-2ee6b2130cebURI
-
https://doi.org/10.2337/dc22-1960DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
OBJECTIVE To estimate the risk of progression to stage 3 type 1 diabetes based on varying definitions of multiple islet autoantibody positivity (mIA). RESEARCH DESIGN AND METHODS Type 1 Diabetes Intelligence (T1DI) is a combined prospective data set of children from Finland, Germany, Sweden, and the U.S. who have an increased genetic risk for type 1 diabetes. Analysis included 16,709 infants-toddlers enrolled by age 2.5 years and comparison between groups using Kaplan-Meier survival analysis. RESULTS Of 865 (5%) children with mIA, 537 (62%) progressed to type 1 diabetes. The 15-year cumulative incidence of diabetes varied from the most stringent definition (mIA/ Persistent/2: two or more islet autoantibodies positive at the same visit with two or more antibodies persistent at next visit; 88% [95% CI 85–92%]) to the least stringent (mIA/Any: positivity for two islet autoantibodies without co-occurring positivity or persistence; 18% [5–40%]). Progression in mIA/Persistent/2 was significantly higher than all other groups (P < 0.0001). Intermediate stringency definitions showed intermediate risk and were significantly different than mIA/Any (P < 0.05); however, differences waned over the 2-year follow-up among those who did not subsequently reach higher stringency. Among mIA/Persistent/2 individuals with three autoantibodies, loss of one autoantibody by the 2-year follow-up was associated with accelerated progression. Age was significantly associated with time from seroconversion to mIA/ Persistent/2 status and mIA to stage 3 type 1 diabetes. CONCLUSIONS The 15-year risk of progression to type 1 diabetes risk varies markedly from 18 to 88% based on the stringency of mIA definition. While initial categorization identifies highest-risk individuals, short-term follow-up over 2 years may help stratify evolving risk, especially for those with less stringent definitions of mIA.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Ghalwash, MohamedAin Shams University,IBM Thomas J. Watson Research Center
(författare)
-
Li, YingIBM Thomas J. Watson Research Center
(författare)
-
Ng, KenneyIBM Thomas J. Watson Research Center
(författare)
-
Dunne, Jessica L.Juvenile Diabetes Research Foundation
(författare)
-
Lundgren, MarkusLund University,Lunds universitet,Pediatrisk endokrinologi,Forskargrupper vid Lunds universitet,Paediatric Endocrinology,Lund University Research Groups,Central Hospital Kristianstad(Swepub:lu)med-mn2
(författare)
-
Hagopian, WilliamPacific Northwest Research Institute
(författare)
-
Lou, OliviaJuvenile Diabetes Research Foundation
(författare)
-
Winkler, ChristianeHelmholtz Zentrum München
(författare)
-
Toppari, JormaTurku University Hospital
(författare)
-
Veijola, RiittaUniversity of Oulu
(författare)
-
Anand, VibhaIBM Thomas J. Watson Research Center
(författare)
-
University of ColoradoAin Shams University
(creator_code:org_t)
-
T1DI Study Group
Sammanhörande titlar
-
Ingår i:Diabetes Care: American Diabetes Association46:10, s. 1753-17610149-59921935-5548
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Frohnert, Brigit ...
-
Ghalwash, Mohame ...
-
Li, Ying
-
Ng, Kenney
-
Dunne, Jessica L ...
-
Lundgren, Markus
-
visa fler...
-
Hagopian, Willia ...
-
Lou, Olivia
-
Winkler, Christi ...
-
Toppari, Jorma
-
Veijola, Riitta
-
Anand, Vibha
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
Diabetes Care
- Av lärosätet
-
Lunds universitet